Epsilon M&A Deal Report - Menix Group
Transaction Multiples for the Valuation of Private Companies
Private Group led by FAPI > Menix Group
Announced Date : 03 October 2017
Type : SBO (Secondary Buy Out) ,Exit
Deal Value : Yes
Acquirer : Private Group led by FAPI
Target: Menix Group
Target Country: France
Sector of activity : Health, Pharmaceuticals & Biotechnology
Business Description :
> Formed in 2009 as a result of the merger between Serf and Dedienne Santé, two Frenc ...
Transaction multiples available
| EV/Sales | EV/Gross Profit | EV/EBITDA | EV/EBIT | Eq/PBT | P/E | Price to Book | |
|---|---|---|---|---|---|---|---|
| Historic | |||||||
| Current |
: Multiple available
n.s : Multiple calculated, but not significant
Rating *
Source: Epsilon Research / EMAT
Comparable Transactions
Number of EMAT Reports : (Health, Pharmaceuticals & Biotechnology) = 1228
Example of comparable transactions on EMAT (same sub-sector):
| Date | Acquirer | Target | Country | Multiples | See details |
|---|---|---|---|---|---|
| 08/10/2019 | VAMED | IHSS | United Kingdom | * | |
| 18/05/2017 | Private Group Led by August Equity | Genesis Dental Care | United Kingdom | ** |
Source: Epsilon Research / EMAT
This report is accessible on EMAT, the reference database for private company acquisition multiples
Example of EMAT Report : click here
View Complete ReportEpsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.
Sectors covered by our analysts
Studies & indices published by Epsilon Research Register to receive (free) publications updates
Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).
Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.
Subscribe to EMAT database
